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Objective:Sulfurmustard(bis-2-(chloroethyl)sulfide)isachemicalwarfareagent(mil-
itary code: HD) causing extensive skin injury. The mechanisms underlying HD-induced
skin damage are not fully elucidated. This review will critically evaluate the evidence
showing that oxidative stress is an important factor in HD skin toxicity. Oxidative stress
results when the production of reactive oxygen (ROS) and/or reactive nitrogen oxide
species (RNOS) exceeds the capacity of antioxidant defense mechanisms. Methods:
This review will discuss the role of oxidative stress in the pathophysiology of HD skin
toxicity in both in vivo and in vitro model systems with emphasis on the limitations of
thevariousmodelsystems.Evidencesupportingthetherapeuticpotentialofantioxidants
and antioxidant liposomes will be evaluated. Antioxidant liposomes are effective vehi-
clesfordeliveringbothlipophilic(incorporatedintothelipidbilayers)andwater-soluble
(encapsulated in the aqueous inner-spaces) antioxidants to skin. The molecular mech-
anisms interconnecting oxidative stress to HD skin toxicity are also detailed. Results:
DNA repair and inflammation, in association with oxidative stress, induce intracellular
events leading to apoptosis or to a programmable form of necrosis. The free radical,
nitric oxide (NO), is of considerable interest with respect to the mechanisms of HD tox-
icity. NO signaling pathways are important in modulating inflammation, cell death, and
wound healing in skin cells. Conclusions: Potential future directions are summarized
with emphasis on a systems biology approach to studying sulfur mustard toxicity to skin
as well as the newly emerging area of redox proteomics.
SULFUR MUSTARD: A CENTURY OF THREAT
Sulfur mustard (SM) or mustard gas (bis-2-(chloroethyl) sulfide, military code: HD) is
a chemical warfare agent classified as a weapon of mass destruction. Mustard gas was
one of the first chemical weapons deployed against troops on a battlefield during World
WarI ,almost hundred years ago. Since then, the military use of mustard gas has been
documented in a number of situations. In 1988, HD was used with devastating results
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Figure 1. Distribution and accumulation of HD via circulation after dermal/inhalation exposure.
by Saddam Hussein’s military forces against civilian targets in Halabja and later during
the Iran-Iraq war. Mustard gas produces casualties in the battlefield and forces opposing
troops to wear full protective equipment thus slowing the tempo of military operations. It
is highly probable that mustard gas could be used by terrorists since it is a simple chemical
compound readily synthesized without elaborate technology. Moreover, as a “persistent
agent” (US Army classification) aerosolized mustard gas presents a threat for up to 1 week
under dry and warm weather conditions because it remains in the environment until fully
hydrolyzed. Along with nerve agents, mustard gas presents a major threat as a potential and
effective chemical weapon. The possibility of low technology production, easy stockpiling,
and difficulty in verifying its storage makes mustard gas a continuing worldwide threat.
Presently, there is no antidote or effective treatment for mustard gas intoxication.
PATHOPHYSIOLOGY OF SULFUR MUSTARD ON SKIN
Clinical and physiological characteristics
Mustard gas is lethal in high doses and causes severe damage to the interface organs, that
is, skin, lungs, respiratory tract, and eyes. The most prominent toxic effects of HD are on
skin where it produces severe damage including extremely slow healing lesions and blisters
whichcanulcerate,vesicate,andpromotesecondaryinfections.Becauseofitshydrophobic
nature, mustard gas easily penetrates and accumulates in the lipid component of exposed
tissues. Upon contact with the skin, about 80% of HD evaporates and only about 20% is
absorbed by the skin. Skin not only accumulates but also distributes HD to other tissues.
Onlyabout10%–12%oftheinitiallyabsorbedHDisretainedintheskin,whereasupto90%
of HD enters circulation as indicated in Figure 11 Extractable skin reservoirs of HD can be
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found in the dermis and epidermis even 24 to 48 hours postexposure.2 In the case of a lethal
poisoning, HD concentration in skin blisters remains very high even 7 days after exposure.3
Consequently, even after the initial exposure, skin reservoirs continue to distribute HD
via circulation to the body tissues thereby increasing damage to several organs. Figure 1
schematically shows the distribution pathway of HD toxicity throughout the human body.
We would like to point that, although skin is the initial accumulator of HD, its toxic effect
is also prominent in distal organs. Therefore, the effect of HD after dermal exposure is not
limited only to skin tissues
While the epidermis contains no blood vessels, both the dermis and the subcutaneous
regions are rich in blood vessels. Adipose cells in the subcutaneous skin layer are likely to
be a depository for HD due to their high lipid content (as indicated in Figure 1). Moreover,
HD solublized in adipose cells would be out of contact with water and thereby resistant to
hydrolysis.Afteracuteskinexposure,HDwouldbesystemicallydeliveredtovarioustissues
in the body via lipid rich blood cell membranes and plasma lipoproteins and accumulate in
lipid rich tissues (adipose tissues, brain, and skin). Chemical analyses following acute HD
exposure show a high accumulation in thigh fat, brain, abdominal skin, kidney, and muscle
tissues, in decreasing order.3 In addition, HD can be found in the spleen, liver, and bone
marrow.4 The organs acquiring the most damage after dermal and/or respiratory exposure
are indicated in Figure 1.
Skin damage caused by aerosolized HD appears after a latent period of up to 24 hours.
First symptoms, such as itching, burning, and erythema, are followed by hyperpigmenta-
tion, tissue necrosis, and blister formation in warm moist areas of the body. When a large
skin area is exposed to HD, medical conditions can be complicated by fluid imbalance,
general inflammation, systemic intoxication, and secondary infection. At high doses, HD
can also produce systemic effects with gastrointestinal symptoms (nausea and vomiting),
respiratory distress due to the bronchospasm, temporary blindness as well as corneal dam-
age. In most lethal cases, massive skin burns and wounds, as well as lung damage, are the
primary causes of death. Since it damages DNA, mustard gas promotes mutagenesis and
carcinogenesis.1,5–7 Acute and severe exposures to HD have been shown to produce skin
cancers.8,9
Af ew limited cases of HD exposure in humans provide some evidence for oxidative
stress. HD metabolites derived from hydrolysis (thiodiglycol, thiodiglycol sulphoxide), as
well as HD metabolites from glutathione (GSH) conjugates by the beta-lyase pathway, can
be found in human urine after HD exposure.10,11 Both thiodiglycol sulphoxide and beta-
lyase metabolites can be detected indicating GSH conjugation. Thiodiglycol has also been
detected in urine samples from individuals not exposed to HD and is therefore not useful
as a definitive marker for HD exposure.11 In contrast, HD metabolites from the glutathione
(GSH)/beta-lyase pathway are specific for HD exposure.10,11 These observations suggest
that GSH depletion occurs in humans, and that GSH-HD/beta-lyase pathway metabolites
provide a specific and useful biomarker for diagnosing HD exposure. GSH is a key in-
tracellular antioxidant and its depletion by HD would be expected to increase oxidative
stress.
The effects of HD in humans are very complicated and not fully elucidated. Figure 2
summarizes some of the key potential molecular mechanisms for HD toxicity in skin cells
(as discussed in more detail below). Macromolecular damage and thiol depletion are pri-
mary and presumably the most dangerous intracellular events following HD exposure to
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Figure 2. Schematic representation of the hypothesized molecular mechanisms of HD toxicity in
skin cells.
skin cells. Macromolecular damage includes DNA damage as well as covalent modifica-
tion of proteins and inactivation of enzymes. HD can affect cellular proteins indirectly by
influencingexpressionanddirectlybyalteringthefunctionofvariousenzymesandcausing
fragmentation of the extracellular matrix and cell detachment. GSH and total cellular thiol
depletionisconsideredtobethemajorsourceoftheoxidativestress.Theseprimarydamag-
ing events modulate gene expression and induce inflammation and oxidative stress, which
finally leads to apoptosis and/or necrosis (see Fig 2).
GENERAL COUNTERMEASURES
Presently, elimination of contact, decontamination, and supportive therapies are the only
primary treatments for vesicant exposure. Respirators and protective masks are effective
in preventing inhalation, and special protective clothing can be used to eliminate skin
exposure. Various decontaminating agents can eliminate or effectively reduce the toxic
effect of HD if used immediately after the exposure. Ambergard XE-555 Resin reactive
powder, hypochlorite neutralizing solutions, reactive skin lotions, and absorbent powders
can be used to remove HD from human skin. Substantial HD reservoirs can be found in
human skin even 24 hours after exposure.12 These reservoirs can account for up to 35% of
thetotaldose,anditisimportant,therefore,todevelopdecontaminatingtechniquescapable
oftheremovingsuchreservoirstherebyreducingfurtherskinandsystemicdamage.Graham
et al13 have provided an excellent review of the strategies and current therapies for treating
63JOURNAL OF BURNS AND WOUNDS VOLUME 7
cutaneous HD toxicity and promoting wound healing. An optimal therapeutic approach is,
however, still lacking.
Inthisreview,wewillfocusonthepotentialroleofantioxidanttherapy;wewillreview
the data from in vivo and in vitro models suggesting that oxidative stress is an important
molecular mechanism underlying HD toxicity and that antioxidants can be therapeutically
useful. The strengths and limitations of the in vivo and in vitro models will be detailed.
MUSTARD GAS/ANALOG-INDUCED OXIDATIVE STRESS IN ANIMAL
MODELS AND THE EFFECTS OF ANTIOXIDANTS
Detailed information about HD toxicity to human skin, especially at the molecular level,
is very limited. Animal models are, therefore, the major source of information about the
pharmacokinetics and the molecular mechanisms of HD skin toxicity. Unfortunately, there
is no animal model that exactly mimics the development of HD injury in human skin.
Young swine and miniature swine skin are, however, considered to be the best models
since they have a similar skin structure (epidermis, dermis, and subcutaneous tissue) and
barrier function. Furred animals are poor models probably because their skin is not as well
keratinized as human skin, thereby permitting more rapid penetration of drugs or toxins.
Despite limitations, the mouse ear model, the rabbit, the hairless guinea pig, the nude
mouse, and the weanling swine have all been useful for studying the (1) pathophysiology,
(2) molecular mechanism of action, and (3) efficacy of countermeasures for HD injury.
Studies on the Yucatan mini-pig have demonstrated that laminin in the dermo-epithelial
junction is a target for partial protease degradation following HD exposure. The protease
cleavage of laminin networks may account for the blistering effect of HD.14 The logistics
of dealing with even miniature swine has, however, limited their use in HD studies.
In 2002, Naghii15 reviewed much of the existing literature connecting HD toxicity and
oxidative stress and suggested that further studies in animal models were well justified.
Direct evidence for free radical formation in rat lung lavage following inhalation of HD
vaporhasbeenobtainedbyusingelectronparamagneticresonance(EPR)andspintrapping
techniques.16 These studies show a rapid formation of ascorbyl radicals followed by the
formation of carbon-centered radicals.16
Elsayed et al17,18 have demonstrated that subcutaneous injections of either a butyl
2-chloroethyl sulfide (a monofunctional mustard analog) or 2-chloroethyl 4-chlorobutyl
sulfide (a bifunctional mustard gas analog) in animal models caused an elevation in lung
tissue lipid peroxidation as assayed by the thiobarbituric acid (TBA) assay. The TBA assay
is, however, not very specific: rather then directly measuring levels of lipid hydroperoxide,
this assay is generally considered a measure of total “thiobarbituric acid reactive sub-
stances” (TBARS). Total (GSH+GSSG) and oxidized (GSSG) glutathione contents in lung
tissue were found to increase 1 hour and 24 hours after subcutaneous injection of butyl
2-chloroethyl sulfide.18 Subcutaneous injection of 2-chloroethyl 4-chlorobutyl sulfide was
associated with increased GSSG and decreased GSH at 1 hour postexposure. The increased
formationofGSSGandTBARSinlungtissuesfollowingsubcutaneousinjectionofmustard
analogs is consistent with oxidative stress and suggests that dermal exposure can impact
distal organs. This notion is supported by the work of Vijayaraghavan et al,19 who found
that dermally applied HD induces hepatic lipid peroxidation and GSH depletion in mice. In
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this study, the generation of malondialdehyde (MDA) was used as an indirect measure of
lipid peroxidation Vitamin E or flavonoids, while not influencing hepatic GSH depletion,
did reduce MDA levels, suggesting a therapeutic potential.19
The effects of topically applied HD on key antioxidant enzymes have been measured
but with conflicting results. For example, Husain et al20 found that HD decreased the
levels of glutathione peroxidase in white blood cells, spleen, and liver compared to control.
Elsayed et al,18 however, found an increased level of glutathione peroxidase compared to
controls. Elsayed17 interpreted the increased level of glutathione peroxidase (and other
antioxidant enzymes) as an upregulation in response to oxidative stress, whereas Husain
et al20 interpreted the decreased levels of glutathione peroxidase as a potential cause of
oxidative stress. Careful in vitro work with purified enzymes may help clarify these issues.
Despite the importance of skin itself as a primary target for HD toxicity, this organ
has not been extensively studied with respect to oxidative stress. Yourick et al,21 using the
hairless guinea pig model, analyzed the skin NAD+ and NADP+ content as a function of
time after HD exposure. Skin NAD+ content was found to decrease to a minimum after 16
hours(20%ofcontrol)whereasNADP+levelsincreased(260%)between1and2hoursand
returned to control levels at 4 hours. This marked increase in NADP+ levels was thought to
be an early marker of oxidative stress and a contributory factor for HD toxicity.21 Increased
NADP+ levels are a result of increased NADPH consumption: NADPH is a major source of
reducing equivalents for key antioxidant enzymes such as glutathione reductase/peroxidase
and thioredoxine reductase/peroxidase and lack of NADPH would be a source of oxidative
stress.
The data presented above support the view that diminished antioxidant protective
mechanisms are a consequence of HD exposure. It is less clear, however, whether or not the
resulting oxidative stress is a direct contributing factor to mustard toxicity or a secondary
effectduetoinflammation.Inanyevent,theabilityofexogenousantioxidants(asdiscussed
below) to decrease HD toxicity supports the hypothesis that decreasing oxidative stress
and/or inflammation is a viable therapeutic strategy.
Antioxidant protection in animal models
As early as 1985, work by Vojvodic et al22 demonstrated that vitamin E was very effective
in extending the survival time of rats acutely poisoned by HD. Vitamin E is, however, a
generic term referring to at least 4 different tocopherols (alpha-, beta-, gamma-, and delta-)
and 4 tocotrienols (alpha-, beta-, gamma-, and delta-). The particular form of vitamin E
used in the Vojvodic et al experiments was not specified.22 Vitamin E is generally con-
sidered to be the primary lipid soluble antioxidant but it is now recognized that vitamin E
has important “nonantioxidant” roles in modulating various signal transduction and gene
regulation pathways.23–25 Moreover, the different chemical forms of vitamin E are now
known to have distinct chemical and biological properties.26,27 It is important, therefore,
to specify the particular chemical and stereochemical form of vitamin E used in a given
experiment.
Superoxide dismutase (SOD, EC 1.15.1.1) is a key antioxidant enzyme that catalyzes
thedismutationofsuperoxideradicalsintooxygenandhydrogenperoxide.Eldadetal28stud-
ied the therapeutic role of both Cu-Zn-SOD (cytosolic form) and Mn-SOD (mitochondrial
form) in HD skin damage, using the Hartley guinea pig model. Pretreatment of the animals
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by intraperitoneal injection with either form of SOD resulted in a dramatically reduced skin
lesion area induced by HD.28 Treatment with SOD was, however, not effective when given
1hourafterHDpoisoning.28 Thesedatastronglysuggestthatsuperoxideradicalsplayakey
role in HD-induced skin toxicity. Superoxide radicals alone are not a particularly damaging
form of free radicals but they rapidly react with nitric oxide radicals to form peroxynitrite,
which is a potent oxidant capable of causing tissue damage.29–31
HD and its analogs are alkylating agents that chemically react with and deplete bi-
ological thiols such as GSH, which is a key intracellular antioxidant. By promoting ROS
generation and lipid peroxidation (as discussed above), HD will also promote the consump-
tion of GSH and a reduced level of NADPH (see above) will inhibit the regeneration of
GSH from GSSG. It is reasonable, therefore, that exogenous GSH or N-acetyl-L-cysteine
(NAC) would help minimize oxidative stress induced by HD or its analogs. Kumar et al32
tested the potential protective effect of GSH given to Swiss albino female mice follow-
ing acute exposure to HD by either inhalation or percutaneous routes. GSH was admin-
istered by intraperitoneal injection and the dose was 400 mg/kg of body weight, which
translates into about a 20 mM concentration in blood. Survival time following inhalation
exposuretoHDwasincreasedbyGSHadministrationaswellas2otherantioxidants:trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), which is a water-soluble
derivative of alpha-tocopherol, and quercetin, which a flavonoid.32 Inhalation exposure
to HD depleted hepatic GSH levels, and increased hepatic and lung lipid peroxidation (as
indirectly measured by MDA levels), and exogenous GSH was able to reduce lung and
hepaticlipidperoxidationaswellaspreventGSHdepletioninthesetissues.32 Noneofthe3
antioxidants tested were able to significantly increase survival time following percutaneous
exposuretoHDbutexogenousGSHwaseffectiveinpreventingGSHdepletioninbloodand
liver.Surprisingly,lunglevelsofGSHwerenotalteredbypercutaneousHDexposure.32 The
data present in work by Kumar et al32 show that the potential effectiveness of antioxidant
therapy is dependent on the route of HD exposure.
The role of GSH and NAC (and other antioxidants) in attenuating acute lung injury by
2-chloroethyl ethyl sulfide (CEES) has recently been studied in a rat model in which lung
damagewasquantitativelymeasuredbytheextravasationof125-I-bovineserumalbumininto
theextravascularcompartment.33,34 CEESisamonofunctionalanalogofHDthathasproven
very useful in mimicking HD exposure. When the experimental animals were depleted of
either complement or neutrophils prior to CEES exposure (by intrapulmonary injection)
lung damage was significantly decreased.34 Neutrophil depletion was accomplished by
IP injection of rabbit anti-serum to rat polymorphonuclear neutrophils and complement
depletion by IP injections cobra venom factor.34 Antioxidants such as catalase, dimethyl
sulfoxide, dimethyl urea, resveratrol, and NAC all provided significant protection in this
animalmodel.34 NAC (anacetylatedformof L-cysteine)candirectlyfunctionasfreeradical
scavenger and its metabolites are capable of stimulating GSH synthesis.35 NACw as found
to be the most effective antioxidant among those tested33,34 and was effective even when
given up to 90 minutes after lung exposure to CEES.
In the work of McClintock et al,33 NACw as superior to GSH. In vitro work by Gross
et al36 found that pretreatment of human peripheral blood lymphocytes (PBL) with 10 mM
NAC elevated GSH level to 122% of untreated control but caused only a partial protec-
tive effect on HD-induced cytotoxicity. These researches also noted work by Meister and
Anderson, suggesting37 that exogenously added GSH does not appear to enter the cell very
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effectively. This may help explain why NAC is superior to GSH in the work by McClintock
et al.33
Bhat et al38 have studied the potential therapeutic use of lipoic acid to decrease ox-
idative stress and mustard gas toxicity in a rat model. Lipoic acid is a disulphide derivative
of octanoic acid, and it is known to be a crucial prosthetic group for various cellular en-
zymatic complexes. Lipoic acid has been identified as a potent antioxidant and a potential
therapeutic agent for the prevention or treatment of pathological conditions mediated via
oxidativestress,asinthecaseofischemia-reperfusioninjury,diabetes,radiationinjury,and
oxidative damage of the central nervous system.39–43 Lipoic acid is taken up and reduced
by cells to dihydrolipoate, a more powerful antioxidant than the parent compound, which
is also exported to the extracellular medium; hence, protection is affected in both extra-
cellular and intracellular environments. Both lipoic acid and dihydrolipoate, in addition to
their direct antioxidant properties, have been shown to regenerate, through redox cycling,
other antioxidants such as vitamin C and vitamin E, and to raise intracellular glutathione
levels.44,45 Bhat et al38 found that lipoic acid pretreatment decreased the levels of lipid
peroxidation (measured as MDA) in lung, skin, and eyes in HD treated rats but was not
effective posttreatment.
Antioxidant liposomes as a potential countermeasure
Antioxidant liposomes may represent an optimal means of treating HD-induced skin le-
sions. The authors’ laboratory is currently testing this hypothesis. The term “antioxidant
liposome” is relatively new and refers to liposomes containing lipid soluble chemical an-
tioxidants, water-soluble chemical antioxidants, enzymatic antioxidants, or combinations
of these various antioxidants. Antioxidant liposomes hold great promise in the treatment
of many diseases and conditions in which oxidative stress plays a prominent role.46,47
The relative ease of incorporating hydrophilic and lipophilic therapeutic agents into li-
posomes; the possibility of directly delivering liposomes to an accessible body site; and
the relative nonimmunogenicity and low toxicity of liposomes have rendered this sys-
tem highly attractive for drug delivery. Moreover, several studies have clearly indicated
that the liposomal antioxidant formulations, compared to that of the free nonencapsulated
antioxidants, exert a far superior protective effect against oxidative stress-induced tissue
injuries.48
Experimental studies have shown that liposomes and their constituents effectively
penetrate skin.49,50 Topical application of antioxidant-liposomes is likely, therefore, to be
particularly effective in enhancing the antioxidant status of skin. Work by Kirjavainen
et al49 suggests that liposomes containing dioleylphosphatidyl ethanolamine (DOPE) are
better able to penetrate into the stratum corneum than liposomes without DOPE. Sim-
ilarly, ultradeformable liposomes, lipid vesicles with special membrane flexibility due
to incorporation of an edge activator such as sodium cholate, have been shown to be
superior in comparison to ordinary phosphatidylcholine liposomes (see http://www.skin-
forum.org.uk/abstracts/ebtassam-essa.php).
At present there are no data on the potential use of antioxidant liposomes in treating
HD-induced skin lesions but McClintock et al33 have found that liposomes containing
pegylated (PEG) catalase, PEG-SOD, or the combination were very effective in reducing
67JOURNAL OF BURNS AND WOUNDS VOLUME 7
CEES-induced lung injury in a rat model. Similarly, liposomes containing NAC, GSH, or
resveratrol also were effective according to this study.
In vitro studies using human skin models
Keratinocyte cell lines
In vivo models are essential for testing countermeasures to HD or its analogs, however,
in vitro models are also critical for rapid screening of potential therapeutic agents and for
detailed studies at the molecular level. Skin is the largest organ of the human body with
a complicated multilayer multicell type structure. As mentioned above, there is no model
system perfectly mimicking human skin. Normal or immortalized human keratinocytes
cultured on plastic as a monolayer represent the simplest and least inexpensive model
and are suitable for an initial approach for HD toxicity studies. Normal human epidermal
keratinocytes (NHEK) isolated from adult or infant fetal skin tissue are available commer-
cially.Thesecellsareeasytohandle,canbefrozenforlong-termstoragebutrequirespecial
medium containing a mixture of growth factors.51 Even then, NHEK cells spontaneously
transform after 3–5 passages as they continuously undergo terminal differentiation.
Nevertheless, NHEK remains the only commercially available normal cell line pos-
sessing all of the structural and functional features of normal skin keratinocytes and is
being used by many investigators to study mustard gas toxicity.52 However, the requirement
of special growth medium and a short lifespan make this model more expensive than im-
mortalized human keratinocytes such as human pappiloma virus (HPV)–immortalized cell
linesorspontaneouslyimmortalizedHaCaTcells.Therearealsoanumberofcommercially
available human keratinocyte cell lines immortalized via transfection with DNA coding E6
and/orE7viraloncoproteins.Allofthesecelllinesstillrequirespecialmediumwithgrowth
factors and, like NHEK, have a limited lifespan since they spontaneously transform after
10 to 15 passages.53
TheHaCaTcellline,originatinginGermany,hasrecentlybecomecommerciallyavail-
able; it represents spontaneously immortalized adult human keratinocytes.54 HaCaT cells
are extremely easy to handle and do not require special medium. Theoretically, HaCaT
cellshaveanunlimitedlifespanbuttheydoshowmorphologicalchangesafter10to20pas-
sages.Despitethealteredgrowthpotential,HaCaTcellsstillexpressdifferentiation-specific
markers54 and unlike HPV-immortalized cell lines, HaCaT cells are not tumorigenic when
transplanted into nude mice.54
It is well known that HD, like UV radiation, affects mostly proliferating keratinocytes
within the lower dermis and basement membrane. Differentiating keratinocytes of the epi-
dermisaremuchlesssusceptibletotoxicitysincetheydonotundergoapoptosisandrespond
weakly to inflammatory stimuli. Normal keratinocytes undergo terminal differentiation
(so-called “cornification”) in response to a high (1 mM) exogenous Ca++ concentration.51
Normal keratinocytes in vivo start to differentiate when they detach from the basement
membraneandmigratetothesuprabasallayers.55 Thus,NHEKandHPV-immortalizedker-
atinocytes,unlikeHaCaTcells,spontaneouslydifferentiatewhensubculturedinresponseto
thecelldetachment.Therefore,onlythefirstpassagesofNHEKcellsaretrulyproliferating,
whereas every passage of HaCaT culture consists of proliferating cells. On the other hand,
HaCaT cells show impaired production and release of IL-156 which is crucial for normal
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keratinocyte proliferation and also plays an important role in keratinocyte activation and
keratinocyte/fibroblast crosstalk in normal skin.57
Aspreviouslyacknowledged,HD-induceddepletionofintracellularglutathione(GSH)
is a triggering event for oxidative stress in skin. Smith et al58 have shown that pretreatment
of the human keratinocyte cell line, SVK-14, with GSH markedly increases the resistance
to HD-induced cytotoxicity. Conversely, pretreatment with buthionine sulfoximine (BSO)
increases the sensitivity of G361, SVK14, HaCaT, and NCTC 2544 human keratinocytes
to HD toxicity.59 BSO lowers intracellular GSH by irreversibly inhibiting the rate-limiting
GSH synthesis enzyme γ-glutamylcysteine synthetase. Surprisingly, there is no reported
direct evidence to date for the enhanced generation of ROS and/or RNOS in HD-treated
keratinocytes.
Aspointedoutearlier,HDanditschemicalanalogscausemassiveleukocyteinfiltration
in animal skin and lungs60,61 It is likely that lymphocytes and macrophages, attracted to the
burned area by cytokines released from keratinocytes/fibroblasts, could be a major source
of oxidative stress to skin cells. It has been demonstrated that HD-exposed NHEK cells
express chemoattractants and cytokine.62–64 Moreover, an enhanced ability of NHEK cells
to attract lymphocytes in vitro was demonstrated in an experiment in which the media from
HD-treated keratinocytes was tested for chemoattractant activity to polymorphonuclear
leukocytes purified from human blood.65
Multilayer keratinocyte tissues
Multilayer skin tissues (so-called “3D skin models”) are a more realistic model for toxi-
cological studies. The simplest models of this class consist only of keratinocytes such as
the commercially available Epiderm, which is a few millimeters thick structure of human
NHEK cells grown on top of a wet membrane. Epiderm provides the possibility of applying
HD (or other gaseous agents) in vapor or aerosol form which closely simulates a real HD
attack. However, this model represents differentiating keratinocytes on a collagen matrix
and practically all of the cells within the tissue start to cornify at the moment they are fully
grown. Blaha et al66–68 have characterized the ultrastructural, histological, and molecular
response of the Epiderm model to CEES. The Epiderm system not only has great potential
for identifying and developing sulfur mustard therapeutic agents but also has limitations.
In vivo, skin damage would be accompanied by the rapid leakage of serum, leukocyte in-
filtration, and perhaps mast cell degranulation (see below) but these events will not occur
in any of the available in vitro skin models.
More advanced tissue models, like EpidermFT full thickness skin tissue model, con-
sist of 2 cell types: a bottom layer of human fibroblasts imbedded in gelatin and an upper
multilayerofhumankeratinocytes.Thisparticularmodelisparticularlyvaluableforstudies
involving paracrine signaling (keratinocyte/fibroblast interactions). HaCaT cells, with nor-
malhumanormousefibroblasts,havealsobeenusedtoconstruct3Dmodelsofhumanskin.
However,theimpairedIL-1productioninthesecellspresentssometechnicaldifficultiesthat
can be overcome with the addition of human growth factors.56 These multilayer skin mod-
els morphologically mimic the dermis and epidermis of human skin including the cuboidal
appearance of the basal cell layer, the presence of the stratum spinosum and stratum gran-
ulosum with typical stellate-shaped keratohyalin granules, and the presence of numerous
lamellar bodies that are extruded at the stratum granulosum–stratum corneum interface.
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In a key experiment, Blaha et al67 compared the effects of CEES on the secretion
of key inflammatory mediators using 2 model human skin systems, the Epiderm system
(from MatTek Corporation) and the Skin2 system (a 3D skin model) from Advanced Tissue
Sciences, which consists of differentiating keratinocytes on a fibroblast-collagen matrix. In
the Skin2 system, the proinflammatory cytokine IL-1alpha increased in response to CEES
but the proinflammatory cytokine IL-6 decreased: the Epiderm showed undetectable levels
of IL-6 and the levels of IL-1alpha did not change in response to CEES.67 These data
show that the presence of fibroblasts in the Skin2 model dramatically changes the cytokine
secretion response to CEES.
Morerecently,Haydenetal69evaluatedtheeffectsofHDontheEpiDermFTskinmodel
which has a 3D, highly differentiated human skin-like structure with an epidermis and a
dermis. This in vitro model permits the study of dermal phenomena in which fibroblast-
keratinocytecellinteractionsareimportantasappearstobethecaseforCEES-inducedskin
injury(seeabove).Haydenetal69 treatedtheEpiDerm-FTmodelwithHDfor8minutesand
evaluatedthestructuraleffectsat6and12hourspostexposure.Histologicalanalysesshowed
typical HD targeting of basal keratinocytes (cytopathology, condensed chromatin, pyknotic
nuclei,andincreasedeosinophilia)andepidermalcleavageatthedermal/epidermaljunction.
Transmission electron microscopy showed that lamina densa of the basement membrane to
be largely intact. The EpiDerm-FT model represents a major advance in the development
of human skin models and its use in studying the molecular mechanisms/proteomics for
HD/CEES toxicity is just beginning to be exploited.
Human skin allografts in immunodeﬁcient mice
Athirdclassofhumanskinmodelisprovidedbytheuseofhumanskinallograftsinimmun-
odeficient mice. Human skin cells, either genetically modified70 or normal,71 were grafted
onto nude mice and successfully used to examine HD-induced biochemical alterations in
skin.In1995,Rosenthaletal70 describedanengineeredhumanskinmodel,inwhichhuman
keratinocyte clones, with some genetic modifications, were grafted onto nude mice, where
they formed histologically normal human skin. Later, the same group reported an advanced
model developed in immunodeficient nude mice, where a pellet of cells containing human
keratinocytes and fibroblasts were placed on top of the muscular layer at the graft site and
grown for 1 week.71 Glass bulbs filled with HD can be directly applied to the sections of
mouse skin containing the human skin allograft. Although these in vivo models are expen-
sive and complicated, they possess a number of advantages over any of the in vitro cultured
skin models. Grafted human skin models make it possible to obtain a detailed picture of
HD-induced morphological, ultrastructural, and inflammatory alterations in various layers
of skin cells possessing the realistic complexity of multiple cell–cell interactions. Recently,
3D human skin allografts in mice have allowed investigators to identify distinctive pre-
vesication and postvesication phases and to monitor both dermal-epidermal separation and
basal membrane alterations in response to HD exposure.72,73 However, a limitation of this
model is the lack of a functional immune response in the recipient mice.
In spite of the ever higher degrees of physiological complexity, there is not a single
model that reflects all the features of human skin. The choice of a particular model may,
therefore, be dictated by the particular experimental design and goals. Wound healing
studies, for example, would require an in vivo system with an intact immune system since
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immune cells are known to contribute to skin regeneration. Moreover, immune cells are
thought to play important roles both in HD-induced skin inflammation and in postexposure
woundhealingthroughtheexpressionofproinflammatorycytokines(suchasIl-1β,TNF-α,
IL-6, and GM-CSF) within the first hour after exposure and proceeding through vesication
and blister formation.64 Leukocyte infiltration always starts shortly after HD treatment in
mice, rabbits, or guinea pigs. In wound healing, leukocytes and macrophages provide many
of the molecular signals regulating fibroblast and keratinocyte proliferation.
The effects of HD on all of the various cell types that come in contact with skin,
including macrophages and mast cells, are also important in understanding the overall ef-
fects of HD on skin in vivo. Rikimaru et al74 have used full-thickness human skin explants
to study inflammatory mediators in response to topically applied HD. These investigators
found that culture fluids from the HD-treated skin contained increased levels of histamine,
plasminogen-activating activity, and prostaglandin E2 compared to control explants. It was
concluded that both mast cells and epidermal cells were apparently involved in early me-
diation of the inflammatory response to HD.74 In contrast, Inoue et al75 found that the
inflammatory response of the mouse ear to HD did not differ in mast cell deficient mice
compared to normal mice. At present, there is no obvious explanation for the differences
observed between the work of Rikimaru et al74 and that of Inoue et al75 It may well be that
themouseearisnotanoptimalmodelforhumanskin.Itiscriticallyimportanttodetermine
whether HD, or other toxic vesicants, degranulate mast cells since this process could be a
major source of inflammatory mediators and, therefore, a major factor in modulating the
immune response to HD. In particular, mast cell degranulation would release large amounts
of TNF-alpha, which is an inflammatory cytokine.
We have previously reported that lipopolysaccharide (LPS) as well as other inflam-
matory factors such as TNF-alpha and IL-1-beta amplify the toxicity of CEES76 and that
CEES is a potent inhibitor of nitric oxide production from inducible nitric oxide synthase
(iNOS).77 LPSisamajorcomponentofthecellwallofgram-negativebacteriaandisknown
to trigger a variety of inflammatory reactions in macrophages and other cells having CD14
receptors.78,79 In particular, LPS is known to stimulate the macrophage secretion of nitric
oxide80 and inflammatory cytokines such as tumor TNF-alpha and IL-1-beta81 Figure 3
shows that RAW 264.7 macrophages stimulated with LPS at 100 ng/mL are markedly
more susceptible (P <. 05) to CEES cytotoxicity (24 hours with 500 µM) than resting
macrophages as indicated by a dramatic drop in dehydrogenase activity as measured by
the MTT ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. In the ab-
sence of LPS, CEES at a level of 500 µM did not significantly affect cell viability.76
Figure 4 shows that CEES (100–500 µM for 24 hours) inhibits the secretion of nitric ox-
ide into the cell medium by LPS stimulated macrophages in a dose-dependent manner77
In these experiments, nitrite secretion into the cell culture medium was used as a mea-
sure of nitric oxide synthesis. Macrophages (and mast cells) are both present in dermal
tissues.
IgE-mediated mast cell degranulation is known to be inhibited by nitric oxide
production.82 NO is a powerful antioxidant83 and increased intracellular levels of NO are
known to inhibit mast cell degranulation.84 Significantly, mast cell degranulation and his-
tamine release are stimulated by membrane lipid peroxidation and inhibited by antioxi-
dants such as alpha-tocopherol.85 Collectively, the information presented above suggests
that HD/CEES could induce mast cell degranulation by increasing oxidative stress and/or
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Figure 3. LPS (100 ng/mL) enhances the cytotoxicity of
CEES (500 µM). Means not sharing a common letter are
significantly different (P < .05). Cytotoxicity was measured
after 24 hours by the MTT assay.
Figure 4. CEES inhibits NO production in LPS stimulated RAW
264.7macrophages.Cellsweresimultaneouslytreatedwithvarious
levels of CEES (as indicated) and low doses of LPS (as indicated).
NO production was monitored as the concentration of nitrite in the
culture media after 24 hours.
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decreasing nitric oxide production. The subsequent release of TNF-alpha could enhance
the cellular toxicity of HD/CEES.
NO generation, mediated by iNOS, is also crucial for the rapid healing of human skin
wounds. Although, keratinocytes are known to express iNOS and generate NO in wound
healing, it is likely that macrophages, known for their ability to express iNOS and generate
high levels of NO, also contribute to the healing stimuli. Thus, it is tempting to suggest
thatthedevelopmentofa3-cell-type(macrophages/fibroblasts/keratinocytes)modelwould
provide a unique and optimal model for studying skin vesication, blistering, and wound
healing under very reproducible experimental conditions.
MOLECULAR MECHANISMS FOR MUSTARD TOXICITY
The molecular mechanisms of HD skin toxicity are complex and not yet fully understood.
We will focus on 3 major types of interrelated events: primary macromolecule damage,
oxidative stress, and inflammation. All of these processes are tightly interconnected and
play central roles in HD toxicity. The hypothesized mechanisms of HD toxic effect in
skin cells are summarized in Figure 2. In addition, we will discuss the importance of NO
signaling modulation in HD toxicity since it is likely to be important for the postexposure
wound healing process in skin.
Primary macromolecule damage
HD easily penetrates both cellular and nuclear membranes due to its hydrophobic nature.
In the cytosol, it reacts with water forming a highly electrophilic ethylene episulfonium
derivative that is the ultimate alkylating agent. DNA alkylation and crosslinking are well-
documented primary intracellular damaging reactions of HD. Extensive DNA damage, due
to alkylating agents, activates and overloads the DNA repair machinery. In particular, DNA
damage induces expression of poly (ADP-ribose) polymerase (PARP), the key regulatory
enzyme involved in DNA repair and hypothesized to regulate cell fate by modulating death
and survival transcriptional programs.86 HD induces PARP expression in normal human
keratinocytes and the possible involvement of this nuclear enzyme in the regulation of HD
cell death mechanisms has been extensively studied.87–91
PARP-1 is the most abundant member of the of PARP protein family. PARP-1 binds
to DNA structures that have single- and double-strand breaks, crossovers, cruciforms, or
supercoils92;i tsignals DNA rupture and facilitates base-excision repair.93,94 Normally, the
intracellularlevelofPARP-1isverylow,andthisenzymecanbedetectedinthecytosolonly
under stressful conditions. Upon binding to the damaged DNA sites, PARP-1 metabolizes
β-nicotinamide adenine dinucleotide (NAD+) into branched polymers of ADP-ribose that
aretransferredtoasetofnuclearproteins.Thisprocessalsoresultsinaverylargedecreasein
thepyridinenucleotidepool.Poly(ADP-ribosyl)ationisthoughttobebeneficialforgenome
repair since modifications of proteins proximal to the DNA breaks facilitate multiple local
openings of the condensed chromatin structure allowing the binding of the repair protein
complex.93,95
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Despite the beneficial effect, PARP can induce apoptosis or necrosis in skin cells
treated with HD91 or other alkylating agents.86,96 Thus, limited expression of PARP pro-
teins helps in DNA repair and promotes cell survival but its overexpression (as in case
of massive DNA damage) can induce cell death.97 PARP overproduction, especially in
cells utilizing aerobic glycolysis, can lead to the depletion of cellular NAD+ and ATP (see
Fig2 )w hich rapidly promotes general intracellular bioenergetic collapse and oxidative
stress resulting in a regulated form of necrosis.86,96,98–100 HD is cytotoxic to both dermal
fibroblasts and epidermal keratinocytes. It has been suggested that PARP determines the
mode of HD-induced cell death in skin fibroblast but not in keratinocytes.91 In mouse
skin fibroblast the absence of PARP shifts the mode of HD-induced cell death shifts from
necrosis to apoptosis,91 whereas keratinocytes, with or without PARP, primarily express an
apoptoticformofcelldeath.91 HD-treatedhumankeratinocytesshowaPARPactivation,an
upregulation of proapoptotic p53 accompanied by a downregulation of antiapoptotic Bcl-2,
and, finally, to caspase activation and apoptosis.87,90 This pathway was found to be Ca++
and calmodulin dependent.90
NecrosisduetoPARP-induceddepletionofNAD+ andATPexhaustionduringaerobic
glycolysis is thought to be the main mechanism of cell death induced by DNA damaging
agents, especially in proliferating cells.96 However, these observations may vary with the
dose of alkylating agent, with cell type and perhaps the particular composition of the
culture medium (see below) in the case of in vitro studies. HD promotes apoptosis in HeLa
cells (10–100 µM),101 peripheral blood lymphocytes (6–300 µM),102 keratinocytes (50–
300 µM),53,87 and endothelial cells (<250 µM).103 A time-dependent shift to necrosis was
observed in HD-treated lymphocytes.102 but a shift toward necrosis is observed at higher
levels of HD in endothelial cells (>500 µM)103 and HeLa (1 mM)101 Interestingly, human
fibroblasts undergo necrosis even at lower concentrations of HD (100–500 µM).91 In most
humancelltypes,apoptosispredominateswithin6–12hoursofpostexposuretime,whereas
necrotic events markedly increase after 12–24 hours.
Countermeasures capable of preventing rapid ATP depletion and mitochondrial dys-
function could be protective against HD-induced necrosis. Unfortunately, this approach
wouldnoteliminatecelldeathcompletelysinceapoptosiswouldlikelyproceed.However,a
shift from necrosis to the less inflammatory apoptotic pathway could possibly be beneficial
by helping eliminate secondary infections and improving wound healing. PARP activation
causes NAD+ depletion and NAD+ is required for glycolysis and pyruvate synthesis.104 In
the absence of pyruvate, mitochondrial respiration fails causing bioenergetic collapse and
cell death via necrosis.86 Therefore, the addition of a mitochondria substrate, such as pyru-
vate, glutamate, or glutamine, to the cell medium could be protective against necrosis.104
A protective effect of pyruvate treatment has, indeed, been documented in genotoxic stress
caused by nitrogen mustard or N-methyl-N -nitro-N-nitrosoguanidine (MNNG), a chemi-
cal analog of HD used as anticancer drugs.96,100,104
Alkyl pyruvates, such as methyl pyruvate and ethyl pyruvate, are excellent alternative
mitochondrial substrates since they (unlike pyruvate) are stable in solution. In aqueous
solutions, pyruvate spontaneously undergoes a series of chemical reactions yielding 2,
4-dihydroxy-2-methylglutarate,whichisamitochondrialpoison.105 Inaddition,alkylpyru-
vatesalsofunctionaseffectiveandpotentscavengersoffreeradicals.Pyruvatesarecapable
of scavenging hydrogen peroxide (H2O2) and the hydroxyl radical (OH&rad;−).106,107 Ad-
ministration of pyruvates was shown to protect against various types of oxidant-mediated
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cellularandorganinjuriesinnumerousinvitroandinvivostudies.108,109 Thesedatafurther
suggest that HD activation of PARP and the subsequent depletion of pyruvate is also a
contributing factor for HD-induced oxidative stress.
In preliminary results, the authors’ laboratory has observed that methyl pyruvate pro-
vides protection to human keratinocytes (HaCaT cell line) treated with CEES and a similar
effect was observed with ethyl pyruvate (unpublished data). It is worth noting that com-
mercially available serum-free media, formulated to culture NHEK cells, contains 0.5 mM
sodiumpyruvate.KeratinocytemediafromGibco,Sigma,andCambrexallcontain0.5mM
pyruvate. It is possible, therefore, that necrosis has not been observed in HD-treated NHEK
cells due to the protective effect of sodium pyruvate in the culture media.
In our experiments (unpublished data), however, we used immortalized HaCaT ker-
atinocytes, which proliferate continuously but do not differentiate. Actively proliferating
cells utilizes aerobic glycolysis and are more susceptible to mitochondrial dysfunction and
necrosis.86,96,100 After limited number of passages NHEK cells, unlike HaCaT cells, un-
dergo terminal differentiation which is a form of cell death different from either apoptosis
or necrosis.55 This difference between HaCaT and NHEK cells theoretically could cause
discrepancies in the cell death pathway caused by HD. Parallel experiments are now being
done with NHEK and HaCaT cells to further characterize the protective effect of pyruvate
to HD/CEES.
Inﬂammation
HD-treated normal human keratinocytes release proinflammatory TNF-α, IL-6, IL-1β in
a dose-dependent manner62 but the particular cytokine profiles observed differ depending
on the skin model used and the dose of HD.63,64,110 Cytokine production and responses
are known to be regulated by the activation of nuclear transcription factor-kappaB (NF-
kappaB) and this activation also plays a key role in determining the fate of a damaged
cell. There are numerous activators of NF-kappaB such as bacterial and viral infections,
chemicaldamage,radiation,andoxidativestress.Inresponsetothesestimuli,anactiveNF-
kappaBproteincomplexisliberatedinthecytoplasmanditsubsequentlytranslocatestothe
nucleus and triggers selective gene expression. Among the genes regulated by NF-kappaB
areadhesionmolecules,pro-inflammatorymediators(IL-1beta,TNF-alpha,interleukin6),
chemokines, IL-8, iNOS, E-selectin, vascular cell adhesion molecule 1 (ICAM-1), and
granulocyte-macrophage colony stimulating factor (GM-CSF).34,111–114 In general, NF-
kappaB activation also triggers antiapoptotic genes and promotes cell survival.
Although the precise mechanism(s) of HD-induced gene expression has not yet been
fully described in skin cells, it is very likely connected to the DNA damaging effect of
HD (see Fig 2) and could, therefore, be PARP-dependent. PARP-1 is known to be a coac-
tivator of NF-kappaB.115;h owever, this pathway has not been fully explored in HD-treated
keratinocytes or fibroblasts. It is also possible that HD modulates NF-kappaB and other
nuclear factors by covalently modifying DNA binding sequences for transcription factors.
Grey et al116 have shown that HD inhibits the in vitro binding of transcription factor acti-
vating protein-2 (AP-2) via alkylating the AP-2 DNA consensus binding sequence rather
than by direct damage to the AP-2 protein.
In addition, it is highly possible that HD-induced oxidative stress also can stimulate
inflammatory responses via transcription factors. Many of the activators of NF-kappaB can
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be blocked with the use of antioxidants.117,118 Transcription factors AP-1,119,120 MAF and
NRL,121,122 and NF-IL6123,124 are regulated by oxygen-dependent mechanisms, and sensi-
tivetoROS.Interestingly,chemicalcompoundsindirectlydisruptingNF-kappaBactivation
induce apoptosis in cancer cells,125–130 whereas inhibitors of NF-kappaB activation protect
HD-treated human keratinocytes.131,132
It is also unclear how exactly the proinflammatory cytokines, such as IL-6, con-
tribute to the HD-induced skin damage. It is known, however, that inflammatory pro-
cesses contribute to the skin damage. In animal models, both skin and lung exposure to
HD or CEES causes massive leukocyte infiltration, which starts shortly after the exposure
and builds up continuously.60,61 The fact that skin burns and blistering have a latent pe-
riod also suggests that secondary responses in skin cells/immune cells also contribute to
the mechanisms of HD toxicity. HD treatment is known to induce NF-kappaB activation
and release of inflammatory cytokines in both keratinocytes and macrophages.63,110,133–135
TNF-alpha, in general, induces apoptosis in keratinocytes and treatment with anti-TNF-
alpha antibodies is protective against UV-induced skin lesions.136 However, the effect of
TNF-alpha in HD-treated skin is complex and an attempt to reduce cell death in normal
human keratinocytes by blocking TNFR1, the major cell receptor for TNH-alphas was not
successful.71
It is likely that keratinocyte activation (see Fig 2) plays an important role in HD toxi-
city. Activation of keratinocytes is a multistep pathway induced in response to skin injury.
Activated keratinocytes are hyperproliferative and able to migrate to the site of injury in
order to form layers of fresh cells in the dermis and epidermis. Activation is regulated by
various cell signaling pathways including TNF-alpha.57,137 Since HD-treated keratinocytes
release high levels of TNF-alpha in the medium,133 we suggest that HD promotes ker-
atinocyte activation, subsequent hyperproliferation, and an enhanced susceptibility to the
PARP-mediated bioenergetic collapse. This series of molecular events would cause a shift
from apoptosis to necrosis. Although a time- or concentration-dependent shift from apop-
tosis to necrosis has been well documented for HD-treated lymphocytes,102 endothelial
cells,103 and HeLa cells,101 such changes have not been noted for human keratinocytes.
As discussed above, this may be due to the fact that NHEK cells are always protected
from necrosis by pyruvate-containing media. The recently documented protective effect of
NF-kappaB inhibitors in NHEK and HaCaT cells treated with HD131,132 also supports our
speculationsincetheseinhibitorsdownregulateTNF-alphawhichwouldimpairkeratinocyte
activation.
WOUND HEALING
NO signaling plays a key role in the inflammation and wound healing.138–140 Animal
studies141 have shown that in iNOS knockout mice, wound healing is impaired but re-
stored by iNOS gene transfer. Lack of NO and impaired expression of iNOS after the
HD exposure are thought to be important events promoting skin burns and blistering. We
have shown that HD treatment inhibits iNOS expression and NO synthesis (see Fig 4) in
LPS-stimulated murine macrophages.77 Suppression of iNOS expression and several pro-
tein activators of wound healing have also been found in human keratinocytes treated with
HD.142
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In keratinocytes, the beginning stage of the wound healing process is determined by
the activation process. Under conditions of physical injury, the keratinocyte cell cycle is ac-
tivated and the cells become hyperproliferative and migrate to the site of injury in response
to chemokines.57,137 Activation of keratinocytes, as well as their return to the healthy basal
phenotype, is controlled by cytokines and growth factors produced by various cutaneous
cell types, including keratinocytes and lymphocytes infiltrated at the wound site. Various
intracellular signaling pathways are involved at the different stages of activation. Interest-
ingly, NF-kappaB activation and consequent autocrine TNF-alpha production occur at the
initial stages of the activation and allow keratinocytes to become hyperproliferative and
migratory.57,137 Activation is terminated when lymphocytes, present at the wound site, re-
lease interferon-gamma (IFN-gamma), which induces the activation of STAT-1 and makes
keratinocytes contract newly deposit fibronectin-rich basement membrane. Finally, trans-
forminggrowthfactor-beta(TGF-beta)secretedbyfibroblastsinducestheexpressionofK5
and K14, fully reverting the keratinocytes to a healthy basal phenotype and making them
responsive to differentiation stimuli.57
In human cells, expression of iNOS, which is the main NO-generating protein in
keratinocytes,143 is regulated synergistically by 2 major pathways: NF-kappaB and STAT-
1.144 As pointed above, both HD and its chemical analog CEES downregulate iNOS ex-
pression in murine macrophages77and human keratinocytes.142 Since NF-kappaB activa-
tion is well documented in NHEK cells,131–133 it is possible that the impaired expression
of iNOS in HD-treated cells could be attributed to a STAT-1-dependent mechanisms. In
addition, the possible STAT-1 inhibition by HD could disrupt the IFN-gamma signal-
ing pathway resulting in keratinocytes unable to terminate their wound healing state.57
Thus, simultaneous HD-induced NF-kappaB activation and STAT-1 inhibition could alter
necrosis, inhibit NO generation, prevent wound healing, and possibly affect vesication and
blistering.
The molecular mechanisms whereby HD alters transcription factors activation are not
fully elucidated. However, it is highly possible that the ability of mustards to alkylate DNA
is involved. As pointed above, HD is capable of chemically modifying both proteins (via
crosslinking of Cys residues) and DNA (via alkylation of guanine rich sequences, and
crosslinking). It seems likely that HD would more effectively damage “more exposed”
regions of DNA with accessibility to transcription factors. Interestingly, Gray116 had shown
that HD inhibits the in vitro binding of transcription factor AP-2 via alkylation of the
guanine-rich consensus DNA sequences but not by directly damaging the AP-2 protein.
It is tempting to assume that other transcription factor functions could be affected by HD
in a similar manner. However, the effects of HD on NF-kappaB and STAT-1α have not
been elucidated and AP-2 remains the only transcription factor studied in relation to HD
toxicity.
Since some transcription factors are sensitive to ROS and to the redox state of the
cell in general, it is likely that oxidative stress, inflammation, and NO signaling are tightly
interconnected in skin and its dynamic responses to toxic agents. Soneja et al145 have
suggested that wound healing could be accelerated under circumstances in which oxidative
stressisminimizedbutNOproductionremainselevated.Ontheotherhand,underconditions
elevating oxidative stress, the toxicity of mustards can be greatly enhanced. For instance,
the HD analog CEES shows much higher toxicity in cells stimulated by LPS, TNF-alpha,
or IL-1beta, which enhance inflammation and oxidative stress.76
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FUTURE DIRECTIONS
A systems biology approach to mustard toxicity
As discussed above, HD toxicity in skin results from a multistep complex mechanism in-
volving a number of signaling cascades and various cell types. It is extremely difficult
to follow each step in this mechanism even in a simple in vitro model. A systems biol-
ogy approach would view HD toxicity as time-dependent disruption of an integrated and
interacting network of genes, proteins, and biochemical reactions. This approach would
emphasize integrating data obtained from transcriptomics, metabolomics, and proteomics
with the purpose of constructing and validating a comprehensive model of HD toxicity.
The computational tools for this task would include network mapping as well as cor-
relation, logical, and kinetic modeling.146 This comprehensive model would be the best
wayt oaddress the question: “how relevant to the HD-induced cell death pathways are
the direct chemical alterations caused by HD to various cellular proteins (oxidation, cross-
linking,andfragmentation)andtheindirectchemicalproteinalterationscausedbyROSand
RNOS?”
A transcriptomic approach to studying HD toxicity is already yielding useful re-
sults. In NHEK cells, DNA array techniques have been applied to studying HD-altered
gene expression,147,148 and mRNA differential display has been used to examine HD-
inducedtranscriptionalmodulationsinhumanepidermalkeratinocytes.149 Microarrayanal-
yses of gene expression in CEES- or HD-exposed mouse skin in vivo have also been
accomplished.147,150 ThesestudiesareprovidingadeeperinsightintothemechanismofHD
toxicity since they have identified a number of genes upregulated at the early (0.5–4 hours)
and intermediate (24 hours) stages of postexposure. DNA array analyses are capable of
providing crucial information regarding the changes in transcriptional activity in the cell
and are useful in the search for “the key” signaling pathways involved in HD toxicity. These
studies will help in the design of evermore effective countermeasures and help identify
key biomarkers for therapeutic efficacy. Proteomic data on HD toxicity are currently very
limited but this approach would complement the previously accumulated microarray data
by helping identify all the key proteins involved in HD toxicity at different stages.
Collectively, the literature reviewed here supports the notion that oxidative stress, free
radicaldamagetobiomolecules,andalterationsinredoxsensitivesignalingpathwaysarekey
factors in understanding vesicant toxicology. It is likely, therefore, that the newly emerging
area of redox proteomics would be particularly useful in understanding HD damage to
skin. Redox proteomics is focused on characterizing (1) the chemical modifications of
specific proteins induced by ROS and RNOS; (2) alterations in specific proteins induced by
changes in redox sensitive transcription factors; and (3) alterations in the function/structure
of specific proteins caused by redox sensitive posttranslational modifications.151–153 In this
regard, small thiols, like GSH, are no longer viewed just as protective antioxidants but
as redox regulators of proteins via glutathionylation or by oxidation of protein cysteine
residue.152 Redox proteomics is rapidly emerging as a very powerful tool for characterizing
and identifying proteins based on their redox state.153 This approach has recently been used
to specifically identify oxidized proteins in Alzheimer’s disease and this information has
provenusefulinidentifyingnewtherapeutictargetsandinprovidingnewmolecularinsights
into disease etiology.154
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Multicomponent antioxidant liposomes
HD,duetoitshydrophobicnature,effectivelypenetratesdeepintotheskinandaffectsmostly
proliferating cells within basement membrane, that is, the lowest layer of proliferating
keratinocytes. These growing cells would be highly susceptible to the PARP-mediated
bioenergetic collapse since they actively utilize aerobic glycolysis. HD is likely, therefore,
to induce necrosis rather than apoptosis in these cells, which would subsequently promote
severeinflammation,skinblistering,andvesication.Thus,itiscriticallyimportanttoprovide
fast and efficient delivery of the desired drugs to the deeper skin layers and liposomes hold
promise in this regard. By encapsulating a lipid soluble thiol, antioxidant liposomes could
also effectively diminish (by direct covalent reaction) the stores of HD in skin lipid depots.
Althoughthisreviewhasemphasizedantioxidants,thereispracticallynolimittothepossible
encapsulated agents that can be incorporated into liposomes and delivered to the skin cells.
These agents could include PARP inhibitors, protease inhibitors, anti-inflammatory agents,
and chemical or enzymatic antioxidants. Currently, we are testing novel formulations of
multiagent antioxidant liposomes containing both antiapoptotic (NAC) and antinecrotic
(ethylpyruvate)agents.Liposomescanalsobeformulatedwithagentsdesignedtoaccelerate
wound healing such as epidermal growth factor, transforming growth factor-β, platelet-
derived growth factor, insulin-like growth factor, keratinocyte growth factor, and fibroblast
growth factor.
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